TGFßR1 (ALK5) Kinase Assay Kit

Catalog #
78819
$850 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The transforming growth factor beta receptor (TGFβR1, also known as ALK5) Kinase Assay Kit is designed to measure the serine/threonine activity of TGFβR1 (ALK5) for screening and profiling applications using ADP-Glo® as a detection reagent. 

Synonyms
TGFBR1, ALK5, SKR4, TGF-beta receptor type-1, TGFR-1, Activin A receptor type II-like protein kinase of 53kD, Activin receptor-like kinase 5 (ALK-5; ALK5), Serine/threonine-protein kinase receptor R4 (SKR4), TGF-beta type I receptor
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Supplied As
The assay kit comes in a convenient 96-well format, with enough purified recombinant TGFßR1 (ALK5) kinase, kinase substrate, ATP, and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied
  • ADP-Glo® Kinase Assay (Promega #V6930)
  • DTT (Dithiothreitol), 1M, optional
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator 
Format
Catalog # Name Amount Storage
101575 TGFβR1* 10 µg -80°C
79334 Kinase Buffer 1 (5x) 1.5 ml -20°C
79686 ATP (500 µM) 100 µl -20°C
  TGFBR1 Peptide (10 mg/ml) 50 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube

UniProt #
P36897
Background

The transforming growth factor beta (TGFB) signaling pathway regulates a wide range of biological and cellular processes including cell growth, differentiation, survival/apoptosis, and migration. TGFβ binds to a type II receptor dimer, which recruits a type I receptor dimer forming a hetero-tetrameric complex. The TGFβ receptor is a transmembrane serine/threonine kinase that phosphorylates proteins of the SMAD (Mothers against decapentaplegic homolog) family. Due to its role in immunosuppression, cancer, and inflammatory diseases, among others, this receptor is an attractive therapeutic target.